Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation: J.H. Hanke, et al.; J. Biol. Chem. 271, 695 (1996) Abstract; Full Text Signal characteristics of G protein-transactivated EGF receptor: H. Daub, et al.; EMBO J. 16, 7032 (1997) Abstract; Full Text Src family-selective tyrosine kinase inhibitor, PP1, inhibits both Fc epsilonRI- and Thy-1-mediated activation of rat basophilic leukemia cells: M. Amoui, et al.; Eur. J. Immunol. 27, 1881 (1997) Abstract The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells: H. Tang, et al.; J. Biol. Chem. 273, 18268 (1998) Abstract; Full Text Tyrosine kinases of the Src family participate in signaling to MAP kinase from both Gq and Gi-coupled receptors: T. Igishi and J.S. Gutkind; BBRC 244, 5 (1998) Abstract Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase: D.J. Osterhout, et al.; J. Cell Biol. 145, 1209 (1999) Abstract; Full Text Structural basis for selective inhibition of Src family kinases by PP1: Y. Liu, et al.; Chem. Biol. 6, 671 (1999) Abstract Reactive oxygen species activate p90 ribosomal S6 kinase via Fyn and Ras: J. Abe, et al.; J. Biol. Chem. 275, 1739 (2000) Abstract; Full Text Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells: J. Geginat, et al.; J. Exp. Med. 194, 1711 (2001) Abstract; Full Text The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes: F. Carlomagno, et al.; Cancer Res. 62, 1077 (2002) Abstract; Full Text The specificities of protein kinase inhibitors: an update: J. Bain, et al.; Biochem. J. 371, 199 (2003) Abstract; Full Text The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases: L. Tatton, et al.; J. Biol. Chem. 278, 4847 (2003) Abstract; Full Text
|